Skip to content
MedsAcross

Medicine

Zosyn in Galaxy Containers 3 g/375 mg per 50 mL injection

Piperacillin and Tazobactam · Intravenous · Wyeth Pharmaceuticals
Available on requestPrescription onlyUS FDA Cold chain

Zosyn in Galaxy Containers 3 g/375 mg per 50 mL injection is a prescription medicine containing Piperacillin and Tazobactam for intravenous use, marketed by Wyeth Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Supplied 12/box—NDC 0206-8862-02 ZOSYN ® Injection in GALAXY Containers should…

Key facts

Active ingredient (INN)
Piperacillin and Tazobactam
Brand
Zosyn in Galaxy Containers
Strength
3 g/375 mg per 50 mL
Dosage form
Injection
Route
Intravenous
Packs
24 bags of 50 mL
Marketing authorisation holder
Wyeth Pharmaceuticals
Manufacturer
Wyeth Pharmaceuticals
Origin register
US FDA, United States
Storage
Supplied 12/box—NDC 0206-8862-02 ZOSYN ® Injection in GALAXY Containers should be stored at or below -20°C (-4°F).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.10Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 March 1998
Identifiers
RxCUI 1659131, 1659134, 1659137 +3DailyMed set ID 8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623NDC 0206-8861Application NDA050750

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
24 bag in 1 box / 50 mL in 1 bag0206-8861-02Wyeth Pharmaceuticals1 March 1998

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 October 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Piperacillin and Tazobactam 3 g/375 mg per 50 mL injection.

Compare 1

Other strengths and forms of Piperacillin and Tazobactam

Clinical summary

Piperacillin and Tazobactam is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of intra-abdominal infections in adult and pediatric patients 2 months of age and older. MedsAcross supplies Piperacillin and Tazobactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Piperacillin and Tazobactam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Zosyn in Galaxy Containers 3 g/375 mg per 50 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.